On the same day that Statistics Canada revealed a higher unemployment rate of 6.7% and a youth unemployment rate of 14.1%, the Carney government made it easier for some employers to hire temporary ...

The martial art skill of Brazilian Jiu Jitsu is now being used as a tool for local law enforcement officers. Spanish police find body amid search for missing US student New poll shows top 2028 ...

The City of Binghamton has taken the first steps towards potentially bringing a new passenger rail line to the city, thanks to a federal program that offers up to half a million dollars. Binghamton ...

Victor Nechita, who served as Tesla’s vehicle program manager for the Cybercab, has announced he is leaving the company. The departure comes just days after the first Cybercab production unit rolled ...

Seabourn Cruise Line will end its submarine program in March, in part due to limited guest interest. Passenger participation rates have been lower than the cruise line had anticipated, it said.

Skokie trustees on Tuesday unanimously approved a limited rebate program aimed at reimbursing homeowners who replaced their own lead service lines — which bring water from water mains into homes ...

Jesse Zanger is the managing editor of CBSNewYork.com. Jesse has previously worked for the Fox News Channel and Spectrum News NY1. He covers regional news around the Tri-State Area, with a particular ...

Iranian Foreign Minister Abbas Araghchi said his country would not negotiate on its ballistic missile program, rejecting a core U.S. demand and further dimming prospects for a breakthrough deal. He ...

NEW YORK, Feb 9 (Reuters) - The software and services industry's recent plunge has ignited fears that the artificial intelligence boom may be reshaping markets in unexpected ways, raising questions ...

Jordan Gross, a former All-American with Utah in the early 2000s, is rejoining the Utes as a member of Morgan Scalley's first-year coaching staff. Over two decades after leaving Utah as an ...

(RTTNews) - Galectin Therapeutics Inc. (GALT) Friday announced that the U.S. FDA has provided written feedback on its development program for Belapectin, the company's investigational galectin-3 ...